Correlation Between Biohit Oyj and NYSE Composite

Can any of the company-specific risk be diversified away by investing in both Biohit Oyj and NYSE Composite at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biohit Oyj and NYSE Composite into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biohit Oyj B and NYSE Composite, you can compare the effects of market volatilities on Biohit Oyj and NYSE Composite and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biohit Oyj with a short position of NYSE Composite. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biohit Oyj and NYSE Composite.

Diversification Opportunities for Biohit Oyj and NYSE Composite

0.22

Correlation Coefficient

Biohit Oyj  NYSE Composite

Modest diversification

The 3 months correlation between Biohit and NYSE is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Biohit Oyj B and NYSE Composite in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NYSE Composite and Biohit Oyj is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biohit Oyj B are associated (or correlated) with NYSE Composite. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NYSE Composite has no effect on the direction of Biohit Oyj i.e., Biohit Oyj and NYSE Composite go up and down completely randomly.

Pair Corralation between Biohit Oyj and NYSE Composite

Assuming the 90 days trading horizon Biohit Oyj B is expected to under-perform the NYSE Composite. But the stock apears to be less risky and, when comparing its historical volatility, Biohit Oyj B is 1.17 times less risky than NYSE Composite. The stock trades about -0.29 of its potential returns per unit of risk. The NYSE Composite is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest  1,815,437  in NYSE Composite on February 6, 2024 and sell it today you would lose (35,648) from holding NYSE Composite or give up 1.96% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.24%
Values	Daily Returns

Biohit Oyj B  vs.  NYSE Composite

Pair Trading with Biohit Oyj and NYSE Composite

The main advantage of trading using opposite Biohit Oyj and NYSE Composite positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biohit Oyj position performs unexpectedly, NYSE Composite can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NYSE Composite will offset losses from the drop in NYSE Composite's long position.

The idea behind Biohit Oyj B and NYSE Composite pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.